Document Detail


Effect of Diclofenac on the Levels of Lipoxin A4 and Resolvin D1 and E1 in the Post-ERCP Pancreatitis.
MedLine Citation:
PMID:  25030943     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVES: Acute pancreatitis is one of the most common complications of endoscopic retrograde cholangiopancreatography (ERCP). Numerous studies have shown that administered nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the incidence of acute pancreatitis after ERCP. Little is known, however, about the mechanism of NSAIDs in preventing pancreatitis (PEP).
METHODS: In this study, we assigned patients to receive a single dose of intramuscular diclofenac 75 mg immediately after ERCP (diclofenac group) or without (control group). The primary outcome measure was the occurrence of PEP. The serum amylase levels were measured before ERCP and at 3 and 24 h post-procedure in all patients. The Lipoxin A4 (LXA4), Resolvin D1 (Rvd1), and Resolvin E1 (RvE1) levels were measured before ERCP, and 3 and 24 h after the procedure in 30 patients from the diclofenac group and 30 patients from the control group.
RESULTS: A total of 120 patients were enrolled and completed the follow-up. The overall incidence of PEP was 13.3 % (16/120). It occurred in four of 60 patients (6.67 %) in the diclofenac group and in 12 of 60 patients (20.00 %) in the control group (p = 0.032). The LxA4, RvD1, and RvE1 levels in the diclofenac group at 3 h after ERCP were significantly increased compared with before ERCP (p < 0.05). Compared with the control group, the LxA4, RvD1, and RvE1 levels in the diclofenac group at 3 and 24 h after ERCP were significantly increased (p < 0.05).
CONCLUSIONS: Intramuscular diclofenac after ERCP can reduce the incidence of PEP. This may be related to the fact that diclofenac can increase the levels of LxA4, RvD1, and RvE1.
Authors:
Xiao-Wen Zhao; Jun-Jun Bao; Cui Hu; Hao Ding; Xiao-Chang Liu; Qiao Mei; Jian-Ming Xu
Related Documents :
22910963 - 24- and 6-month dual antiplatelet therapy after coronary stenting did not differ for cl...
22925113 - The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy.
10520843 - Treatment of chronic bleeding from gastric antral vascular ectasia (gave) with estrogen...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-17
Journal Detail:
Title:  Digestive diseases and sciences     Volume:  -     ISSN:  1573-2568     ISO Abbreviation:  Dig. Dis. Sci.     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-7-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902782     Medline TA:  Dig Dis Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk Factors for Serrated Polyps of the Colorectum.
Next Document:  Which Patients have Greatest Need for Elvitegravir/Cobicistat/Emtricitabine/TenofovirDF-Based Therap...